Literature DB >> 4177871

Lipid composition of the nervous system in Refsum's disease.

M C MacBrinn, J S O'Brien.   

Abstract

The compositions of the major lipids and their constituent fatty acids and fatty aldehydes from cerebral gray matter, white matter, and myelin, spinal cord myelin, and sciatic nerve were determined in a 57 yr old woman who died of Refsum's disease. There were deficiencies of ethanolamine glycerophosphatides (EGP) in gray matter and frontal lobe myelin, and a lipid with the chromatographic properties of lyso-EGP accumulated in all tissues. The proportions of the remaining lipids were nearly normal in the central nervous system tissues. In the sciatic nerve the proportions of sphingolipids were small; this observation is consistent with the severe demyelination noted on pathologic examination. Cholesteryl esters were not detected in any tissue. Phytanate (3,7,11,15-tetramethylhexadecanoate) was present in the glycerophosphatides from each tissue. Higher proportions of phytanate were found in choline glycerophosphatides (CGP) than in EGP or in serine glycerophosphatides (SGP). Hydrolysis with phospholipase established that phytanate was confined to the 1-position of CGP. More phytanate was found in CGP from myelin than from gray or white matter. Fourfold higher proportions of phytanate were found in CGP from sciatic nerve than in CGP from the central nervous system: in sciatic nerve, 24% of the fatty acids of CGP consisted of phytanate. The proportions and compositions of sphingolipid hydroxy fatty acids and odd-numbered fatty acids were normal in each tissue. These findings argue against a defect in sphingolipid alpha-hydroxy acid metabolism in Refsum's disease. The results are consistent with the view that the accumulation of phytanate is responsible for the demyelination.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4177871

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  6 in total

1.  Clinicopathological study of Refsum's disease with particular reference to fatal complications.

Authors:  I V Allen; M Swallow; N C Nevin; D McCormick
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-04       Impact factor: 10.154

2.  Lipid abnormalities in succinate semialdehyde dehydrogenase (Aldh5a1-/-) deficient mouse brain provide additional evidence for myelin alterations.

Authors:  G Barcelo-Coblijn; E J Murphy; K Mills; B Winchester; C Jakobs; O C Snead; K M Gibson
Journal:  Biochim Biophys Acta       Date:  2007-01-04

Review 3.  Biochemistry and genetics of inherited disorders of peroxisomal fatty acid metabolism.

Authors:  Paul P Van Veldhoven
Journal:  J Lipid Res       Date:  2010-06-17       Impact factor: 5.922

4.  Role of lipids in the Neurospora crassa membrane: IV. Biochemical and electrophysiological changes caused by growth on phytanic acid.

Authors:  K J Friedman; D Glick
Journal:  J Membr Biol       Date:  1982       Impact factor: 1.843

5.  Refsum's disease: characterization of the enzyme defect in cell culture.

Authors:  J H Herndon; D Steinberg; B W Uhlendorf; H M Fales
Journal:  J Clin Invest       Date:  1969-06       Impact factor: 14.808

6.  Tissue distribution of phytanic acid and its analogues in a kinship with Refsum's disease.

Authors:  J K Yao; P J Dyck
Journal:  Lipids       Date:  1987-02       Impact factor: 1.880

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.